Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO) is a prominent Italian multi-disciplinary cooperative group dedicated to the advancement of clinical research and treatment standards in neuro-oncology. The organization facilitates collaborative clinical trials, primarily focusing on primary brain tumors such as glioblastoma and low-grade gliomas, as well as brain metastases. GICNO integrates expertise from neurosurgery, oncology, radiotherapy, and neuroradiology to optimize therapeutic protocols and improve patient outcomes. By coordinating multi-center studies across Italy, the group contributes significant data to the global understanding of central nervous system malignancies and helps establish national treatment guidelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gruppo Italiano Cooperativo di Neuro-Oncologia.